Skip to content

Establishment of an Emergency and Critical Care Biobank and Multi-omics Precision Subtyping Study

Establishment of an Emergency and Critical Care Biobank and Multi-omics Precision Subtyping Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128607
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical and emergency conditions, including sepsis, acute stroke, acute myocardial infarction, ARDS, pulmonary embolism, cardiac arrest, acute aortic dissection, acute poisoning, etc.

Interventions

Critical and Severe Illnesses:None

Sponsors

Shanghai Minhang District centeral hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years old, regardless of gender; 2.Meet the latest international diagnostic criteria for specific critical illnesses (e.g., Sepsis-3); 3.Expected ICU length of stay = 48 hours; 4.The patient or their legal representative agrees to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Aged < 18 years old; 2.End-stage malignant tumors; 3.Long-term administration of high-dose immunosuppressants or cytotoxic drugs prior to enrollment; 4.Severe primary immunodeficiency diseases or hematological malignancies; 5.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Primary clinical endpoint: A total of no less than 300 eligible subjects shall be enrolled;

Secondary

MeasureTime frame
28-day and 90-day all-cause mortality;

Countries

China

Contacts

Public ContactSun Keyu

Shanghai Minhang District centeral hospital

hoceima@126.com+86 21 64923400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026